Skip to main content
For COVID-19 vaccine updates, please
review our information guide
and
sign up for Connect
. Continue your routine care with us by scheduling an
in-person appointment
or
Video Visit
.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Myeloma Center
Explore this Website
Home
About Us
Toggle menu options
Our Team
Patient Testimonials
News
For Patients
Toggle menu options
Health Information Library and Patient Resources
Support Groups and Helpful Links
Frequently Asked Questions
Your First Visit
Toggle menu options
Self-Referral
Lab Work/Procedures
Referring Physicians
Toggle menu options
Refer a Patient
Research and Clinical Trials
Toggle menu options
Basic and Translational Research
Bibliography
Contact Us
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
For Patients
Referring Physicians
Research and Clinical Trials
Contact Us
Home
Bibliography
Bibliography
Basic and Translational Research
Bibliography
Bibliography
Found 5 results
Author
Title
Type
[
Year
]
Filters:
Author
is
Siegel, David
[Clear All Filters]
2017
Dimopoulos MA
,
A Stewart K
,
Masszi T
,
Spicka I
,
Oriol A
,
Hajek R
,
Rosiñol L
,
Siegel D
,
Mihaylov GG
,
Goranova-Marinova V
et al.
. 2017.
Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study.
.
Br J Haematol. 177(3):404-413.
Ou Y
,
Doshi S
,
Nguyen A
,
Jonsson F
,
Aggarwal S
,
Rajangam K
,
Dimopoulos MA
,
A Stewart K
,
Badros A
,
Papadopoulos KP
et al.
. 2017.
Population Pharmacokinetics and Exposure-Response Relationship of Carfilzomib in Patients With Multiple Myeloma.
.
J Clin Pharmacol. 57(5):663-677.
2016
Avet-Loiseau H
,
Fonseca R
,
Siegel D
,
Dimopoulos MA
,
Spicka I
,
Masszi T
,
Hajek R
,
Rosiñol L
,
Goranova-Marinova V
,
Mihaylov G
et al.
. 2016.
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma.
.
Blood. 128(9):1174-80.
2013
Siegel D
,
Martin T
,
Nooka A
,
R Harvey D
,
Vij R
,
Niesvizky R
,
Badros AZ
,
Jagannath S
,
McCulloch L
,
Rajangam K
et al.
. 2013.
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies.
.
Haematologica. 98(11):1753-61.
Kaufman JL
,
Niesvizky R
,
Stadtmauer EA
,
Chanan-Khan A
,
Siegel D
,
Horne H
,
Wegener WA
,
Goldenberg DM
. 2013.
Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma.
.
Br J Haematol. 163(4):478-86.